Re: Thoughts on ZCC
in response to
by
posted on
Sep 15, 2021 09:28PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
,,,Hummmmm,,unfortunately rsponsibility comes with that CEO chair,,,,,it is very clear Don has had absolutley no concept of costs or timing on trials or deals,,,,,,and investors on the sidelines know perfectly well this company has morphed into a full fledged dog and pony show,,,,,,its down to only a few shareholders who still bat their eyelashes on his every word,,,if you havent noticed ,,his every word is really an MT promise or misguided belief,,,as noted before it could be some sort of stockholm syndrome for those existing investors. The share price has no bottom,,I have noticed this along with a few others.......a change out the CEO,,maybe,,the BoDs seem to be like the Canadian senate,,,,next to useless,,,who ever is ruining this company its probably not DMcC,,,,he just parrots what Norman or Elewina write down for him,,,,,I will say Hepa drives the ship,,down and down again inorder to take full control of the company,,,,,but never fear those in the compnay chairs will be well compensated on and off the record!!!,,This is a personal opinion from investing in these public markets the past 35 years and seeing a great number of inept managment teams fail their high potential companies!